Dipeptidyl peptidase-4 inhibitors and HbA1c target of

K. Esposito, D. Cozzolino, G. Bellastella, M. I. Maiorino, P. Chiodini, A. Ceriello, D. Giugliano

Research output: Contribution to journalArticlepeer-review


Aim: We assessed the efficacy of dipeptidyl peptidase-4 (DPP-4) inhibitors vildagliptin, sitagliptin, saxagliptin and alogliptin to reach the haemoglobin HbA1c target of 2 value = 0.410, p <0.001). Conclusions: A greater proportion of type 2 diabetic patients can achieve the HbA1c goal

Original languageEnglish
Pages (from-to)594-603
Number of pages10
JournalDiabetes, Obesity and Metabolism
Issue number7
Publication statusPublished - Jul 2011


  • DPP-IV inhibitor
  • HbA1c <7%
  • Meta-analysis
  • RCTs
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Dipeptidyl peptidase-4 inhibitors and HbA1c target of'. Together they form a unique fingerprint.

Cite this